Replies to Post #243067 onBiotech Values | InvestorsHub

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Replies to post #243067 on Biotech Values

Replies to #243067 on Biotech Values

08/05/22 11:10 AM

#243391 RE: DewDiligence #243067

AKBA’s Vadadustat misses primary endpoint in COVID trial:

https://finance.yahoo.com/news/akebia-therapeutics-announces-initial-findings-200200449.html

02/21/23 12:08 PM

#245573 RE: DewDiligence #243067

AKBA -17% on delay to CRL-appeal process:

https://ir.akebia.com/news-releases/news-release-details/akebia-therapeutics-received-interim-response-fda-appeal